Literature DB >> 25349175

T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung.

Shoichi Iriguchi1, Norihiro Kikuchi2, Shin Kaneko1, Emiko Noguchi3, Yuko Morishima4, Masashi Matsuyama4, Keigyou Yoh5, Satoru Takahashi6, Hiromitsu Nakauchi7, Yukio Ishii4.   

Abstract

Although overexpression of T-bet, a master transcription factor in type-1 helper T lymphocytes, has been reported in several hematologic and immune diseases, its role in their pathogenesis is not fully understood. In the present study, we used transgenic model mice (T-bet(tg/wt) and T-bet(tg/tg)) to investigate the effects of T-bet overexpression selectively in T lymphocytes on the development of hematologic and immune diseases. The results showed that T-bet overexpression in T cells spontaneously induced maturation arrest in the mononuclear phagocyte lineage, as well as spontaneous dermatitis and pulmonary alveolar proteinosis (PAP)-like disease in T-bet(tg/wt) and T-bet(tg/tg) mice, respectively. T-bet(tg/tg) alveoli with the PAP phenotype showed remarkable reorganization of alveolar mononuclear phagocyte subpopulations and impaired function, in addition to augmented T-cell infiltration. In addition, PAP development in T-bet(tg/tg) mice was found to be associated with increased migration of myeloid cells from the bone marrow into the peripheral blood. These findings reveal an unexpected link between T-bet overexpression in T lymphocytes and the development of PAP caused by reorganization of mononuclear phagocytes in the lung, and provide new insight into the molecular pathogenesis of secondary PAP accompanied by hematologic disorders.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25349175      PMCID: PMC4300389          DOI: 10.1182/blood-2014-05-575225

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  62 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

Review 2.  Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndromes: a report of four cases detected on autopsy.

Authors:  Nahoko Shoji; Yoshikazu Ito; Yukihiko Kimura; Jiroh Nishimaki; Yuzuru Kuriyama; Tetsuzo Tauchi; Makoto Yaguchi; Dilnur Payzulla; Yoshiro Ebihara; Kazuma Ohyashiki
Journal:  Leuk Res       Date:  2002-06       Impact factor: 3.156

3.  Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice.

Authors:  M Mack; J Cihak; C Simonis; B Luckow; A E Proudfoot; J Plachý ; H Brühl; M Frink; H J Anders; V Vielhauer; J Pfirstinger; M Stangassinger; D Schlöndorff
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

4.  A CD2-green fluorescence protein-transgenic mouse reveals very late antigen-4-dependent CD8+ lymphocyte rolling in inflamed venules.

Authors:  K Singbartl; J Thatte; M L Smith; K Wethmar; K Day; K Ley
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

5.  Alveolar JE/MCP-1 and endotoxin synergize to provoke lung cytokine upregulation, sequential neutrophil and monocyte influx, and vascular leakage in mice.

Authors:  U Maus; J Huwe; R Maus; W Seeger; J Lohmeyer
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

6.  Type I and type II T-cell profiles in aplastic anemia and refractory anemia.

Authors:  H Tsuda; H Yamasaki
Journal:  Am J Hematol       Date:  2000-08       Impact factor: 10.047

7.  GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1.

Authors:  Y Shibata; P Y Berclaz; Z C Chroneos; M Yoshida; J A Whitsett; B C Trapnell
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

8.  Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.

Authors:  Jaroslaw P Maciejewski; Antonio Risitano; Elaine M Sloand; Olga Nunez; Neal S Young
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

9.  Targeted PPAR{gamma} deficiency in alveolar macrophages disrupts surfactant catabolism.

Authors:  Anna D Baker; Anagha Malur; Barbara P Barna; Shobha Ghosh; Mani S Kavuru; Achut G Malur; Mary Jane Thomassen
Journal:  J Lipid Res       Date:  2010-01-11       Impact factor: 5.922

10.  The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.

Authors:  M F Neurath; B Weigmann; S Finotto; J Glickman; E Nieuwenhuis; H Iijima; A Mizoguchi; E Mizoguchi; J Mudter; P R Galle; A Bhan; F Autschbach; B M Sullivan; S J Szabo; L H Glimcher; R S Blumberg
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

View more
  10 in total

1.  Inflammatory responses induce an identity crisis of alveolar macrophages, leading to pulmonary alveolar proteinosis.

Authors:  Risa Ebina-Shibuya; Mitsuyo Matsumoto; Makoto Kuwahara; Kyoung-Jin Jang; Manabu Sugai; Yoshiaki Ito; Ryo Funayama; Keiko Nakayama; Yuki Sato; Naoto Ishii; Yasunobu Okamura; Kengo Kinoshita; Kohei Kometani; Tomohiro Kurosaki; Akihiko Muto; Masakazu Ichinose; Masakatsu Yamashita; Kazuhiko Igarashi
Journal:  J Biol Chem       Date:  2017-09-15       Impact factor: 5.157

2.  Storm Warning: Lung Disease in Systemic Juvenile Idiopathic Arthritis.

Authors:  Peter A Nigrovic
Journal:  Arthritis Rheumatol       Date:  2019-09-22       Impact factor: 10.995

Review 3.  The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis.

Authors:  Bryce A Binstadt; Peter A Nigrovic
Journal:  Arthritis Rheumatol       Date:  2022-05-29       Impact factor: 15.483

4.  Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.

Authors:  Grant S Schulert; Shima Yasin; Brenna Carey; Claudia Chalk; Thuy Do; Andrew H Schapiro; Ammar Husami; Allen Watts; Hermine I Brunner; Jennifer Huggins; Elizabeth D Mellins; Esi M Morgan; Tracy Ting; Bruce C Trapnell; Kathryn A Wikenheiser-Brokamp; Christopher Towe; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2019-10-01       Impact factor: 10.995

Review 5.  Secondary pulmonary alveolar proteinosis: a single-center retrospective study (a case series and literature review).

Authors:  Dongmei Zhang; Xinlun Tian; Ruie Feng; Xiaobei Guo; Peng Wang; Yusen Situ; Yi Xiao; Kai-Feng Xu
Journal:  BMC Pulm Med       Date:  2018-01-25       Impact factor: 3.317

6.  Clinical features of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome: Two case reports.

Authors:  Yin Liu; Lu Lu Chen; Yu Ying Qiu; Yong Long Xiao; Hou Rong Cai
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

7.  Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019.

Authors:  Scott W Canna; Grant S Schulert; Adriana de Jesus; Alex Pickering; Hermine Brunner; Massimo Gadina; Stewart Levine; Raphaela Goldbach-Mansky; Jonathan Boutelle; Rashmi Sinha; Fabrizio DeBenedetti; Alexei Grom
Journal:  Pediatr Rheumatol Online J       Date:  2020-07-15       Impact factor: 3.054

Review 8.  Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.

Authors:  Jasper F Nies; Udo Schneider; Martin Krusche
Journal:  Front Med (Lausanne)       Date:  2022-09-16

9.  ATP catabolism by tissue nonspecific alkaline phosphatase contributes to development of ARDS in influenza-infected mice.

Authors:  Parker S Woods; Lauren M Doolittle; Judy M Hickman-Davis; Ian C Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-05       Impact factor: 6.011

10.  Minimally invasive implantation and decreased inflammation reduce osteoinduction of biomaterial.

Authors:  Zifan Zhao; Qin Zhao; Bin Gu; Chengcheng Yin; Kailun Shen; Hua Tang; Haibin Xia; Xiaoxin Zhang; Yanbing Zhao; Xiangliang Yang; Yufeng Zhang
Journal:  Theranostics       Date:  2020-02-18       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.